BILLEV PHARMA ApS: Financial statements 2019
CVR: 81814813
Source: annual report 2019, Danish Business Authority
01/05/2018 – 30/04/2019
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 17,491,610 and a net result of DKK 2,493,022 compared with DKK 3,726,340 the year before. That is an increase of 2.4% compared with the year before. Equity in the 2019 report amounted to DKK 2,813,022. The solvency ratio was 52.2%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 17,491,610
- Profit/Loss
- DKK 2,493,022
- Equity
- DKK 2,813,022
- Total Assets
- DKK 5,392,825
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
| 2018 | - | 17.1 mio. | 3.7 mio. | 4 mio. | 13 |
| 2017 | - | 14.6 mio. | 2.1 mio. | 2.4 mio. | 13 |
| 2016 | - | - | 2 mio. | 2.3 mio. | - |
| 2015 | - | 9.7 mio. | 636 t. | 956 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Anja Wencke van Arkens and Ulrikke Lynge Jensen. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.